We are live on ! Find out more
APVO icon

Aptevo Therapeutics

hedge funds and large institutions have $29.7M invested in Aptevo Therapeutics in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$2.75M
PA
2
Perceptive Advisors
New York
$2.53M
SC
3
Sessa Capital
New York
$2.5M
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.14M
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$1.27M
EA
6
Emerald Acquisition
Washington
$1.13M
BIT
7
BlackRock Institutional Trust
California
$1.07M
BFA
8
BlackRock Fund Advisors
California
$1.06M
GP
9
GLG Partners
United Kingdom
$1.01M
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$962K
CL
11
CSS LLC
Illinois
$906K
Goldman Sachs
12
Goldman Sachs
New York
$881K
Charles Schwab
13
Charles Schwab
California
$877K
State Street
14
State Street
Massachusetts
$821K
Manulife (Manufacturers Life Insurance)
15
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$818K
Morgan Stanley
16
Morgan Stanley
New York
$665K
Renaissance Technologies
17
Renaissance Technologies
New York
$663K
Northern Trust
18
Northern Trust
Illinois
$593K
AA
19
AQR Arbitrage
Connecticut
$540K
Millennium Management
20
Millennium Management
New York
$429K
Bank of New York Mellon
21
Bank of New York Mellon
New York
$400K
Norges Bank
22
Norges Bank
Norway
$383K
Fidelity Investments
23
Fidelity Investments
Massachusetts
$360K
BG
24
BlackRock Group
United Kingdom
$355K
Geode Capital Management
25
Geode Capital Management
Massachusetts
$259K